| 2/11 |
6:00pm |
HARVARD
BUSINESS
SCHOOL
HEALTH
INDUSTRY
ALUMNI
ASSOCIATION
and
the
HARVARD
HEALTH
CAUCUS
AT
HARVARD
MEDICAL
SCHOOL
invite
you
to
attend
The
Significance
of
Vaccines
in
Global
Health
February
11th,
2004
Conference:
6:00
pm,
Reception
immediately
following.
Harvard
Business
School,
Spangler
Auditorium
Introduction
-
Vaccines:
Reexamining
the
Proven
Armamentarium
Wolfgang
Klietmann,
M.D.,
Lecturer
on
Pathology,
Harvard
Medical
School
Keynote
-
The
Significance
of
Vaccines
in
Global
Health
Raymond
V.
Gilmartin,
President
&
CEO,
Merck
&
Co.,
Inc.
Panel
Discussion
Raymond
V.
Gilmartin,
President
&
CEO,
Merck
&
Co.,
Inc.
Adel
Mahmoud,
M.D.,
Ph.D.,
President,
Merck
Vaccine
Division
Wolfgang
Klietmann,
M.D.,
MS,
Harvard
Business
School
Health
Industry
Alumni
Association
Moderator:
Raj
Shah,
M.D.,
Senior
Policy
Officer
and
Senior
Economist,
The
Bill
and
Melinda
Gates
Foundation
REGISTRATION
FOR
THIS
EVENT
IS
REQUIRED
and
will
be
available
in
January
from
this
HBS
Health
website.
www.hbshealth.org.
Click
on
"Events"
and
then
fill
out
registration
form.
The
Wall
Street
Journal
recently
identified
some
of
the
challenges
facing
the
vaccine
industry,
and
society:
The
malfunctioning
of
the
small
but
vital
marketplace
for
vaccines
in
America;
product
liability
lawsuits
impeding
vaccine
development
and
shrinking
profit
margins
have
driven
many
producers
out
of
this
indispensable
business;
and
the
government
exercise
of
monopsony
power
in
the
vaccine
market.
We
need
a
vital
vaccine
industry
in
collaboration
with
a
well
functioning
reorganized
Public
Health
System
to
contain
menacing
scourges
and
to
keep
contagion
in
check.
The
organizers
of
this
event
gratefully
acknowledge
the
support
of
Boston
Private
Bank.
|